Rahilly Sean 4
4 · Enova International, Inc. · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
Enova (ENVA) GC Sean Rahilly Exercises Options, Sells 12,879 Shares
What Happened
Sean Rahilly, General Counsel and Secretary of Enova International (ENVA), exercised derivatives to acquire 12,879 shares and immediately sold those 12,879 shares in the open market on January 30, 2026. The exercise recorded a cost basis of $20.73 per share (total $266,982). The shares were sold at a weighted average price of $164.28 per share for total proceeds of approximately $2,115,789. The filing also shows the related derivative position was disposed/terminated (reported at $0), consistent with a coordinated exercise/cashless sale.
Key Details
- Transaction date: January 30, 2026 (filed with the SEC on Feb 3, 2026; see note on timeliness below)
- Exercise: 12,879 shares @ $20.73 → $266,982 total (transaction code M)
- Sale: 12,879 shares @ weighted avg $164.28 → ~$2,115,789 total (transaction code S)
- Sale execution detail (F1): executed in multiple trades at prices between $163.415 and $164.95; the reported sale price is the weighted average.
- Derivative disposition: 12,879 shares reported as disposed at $0 (code M), reflecting the related SAR/option settlement.
- Shares owned after the transaction: not specified in the provided excerpt — see the Form 4 for the exact post-transaction holdings.
- Filing timeliness: the report was filed Feb 3 for a Jan 30 transaction; this appears to be after the standard 2-business-day Form 4 window and may be late.
Context
- This is an exercise + immediate-sale (cashless) sequence — the insider exercised a stock option/SAR and sold the acquired shares the same day, a common way to monetize vested awards.
- Footnotes (summary): F2–F3 explain the limited stock appreciation right (SAR) and employee option were granted in tandem (exercise of one causes expiration of the other) and define how SAR payments are calculated; F4 notes the option vested in three roughly equal installments (Feb 11, 2021/2022/2023).
- No indication in the filing of a 10b5-1 plan or other special trading arrangement in the provided excerpt.
- As with all insider sales, this is a factual disclosure and not an explicit signal of company outlook; purchases tend to be more informative about insider sentiment than routine sell-to-cover or cashout transactions.
Insider Transaction Report
- Exercise/Conversion
Common stock, par value $0.00001 per share
2026-01-30$20.73/sh+12,879$266,982→ 113,756 total - Sale
Common stock, par value $0.00001 per share
[F1]2026-01-30$164.28/sh−12,879$2,115,789→ 100,877 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy) with limited SAR
[F2][F3][F4]2026-01-30−12,879→ 15,000 totalExercise: $20.73Exp: 2027-02-11→ Common stock; par value $0.00001 per share (12,879 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $163.415 to $164.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
- [F2]The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- [F3]The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- [F4]The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022 and February 11, 2023.